Crossref
Mortality and morbidity differences with biologic use in hidradenitis suppurativa: a propensity-matched study
Archives of Dermatological Research · 25.07.2026 · 318 (1)
DOI: 10.1007/s00403-026-04673-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 25.07.2026. Verfasst von Sarah Amjad und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Amjad, S., Shao, S., & Chen, S. X. (2026). Mortality and morbidity differences with biologic use in hidradenitis suppurativa: a propensity-matched study. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-04673-w
Vancouver
Amjad S, Shao S, Chen SX. Mortality and morbidity differences with biologic use in hidradenitis suppurativa: a propensity-matched study. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-04673-w
BibTeX
@article{Amjad2026,
author = {Amjad, Sarah and Shao, Samantha and Chen, Stella X.},
title = {Mortality and morbidity differences with biologic use in hidradenitis suppurativa: a propensity-matched study},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-04673-w}
}
EUVIMED